Compare Franco-Nevada Corporation (FNV) vs Altria Group Inc (MO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Franco-Nevada Corporation vs Altria Group Inc — how do they compare? Franco-Nevada Corporation trades at $236.47 (market cap $46.80B), while Altria Group Inc trades at $74.22 (market cap $119.49B). The key difference: Altria Group Inc is far larger — about 2.6× Franco-Nevada Corporation's market cap, and Altria Group Inc pays the higher dividend (6.2%). Which is the better fit depends on your goals — on Pluang, investors hold Franco-Nevada Corporation for 0 Days and Altria Group Inc for 155 Days on average.
| FNV | MO | |
|---|---|---|
Market Cap | $46.80B | $119.49B |
Volume | 310,692 | 6,945,035 |
Sector | Basic Materials | Consumer Staples |
52-Week High | $280.82 | $74.92 |
52-Week Low | $183.97 | $54.72 |
Typical Hold Time | 0 Days | 155 Days |
Enterprise Value | $45.79B | $141.70B |
Dividend Yield | 0.72% | 6.2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Franco-Nevada (FNV) trades at $243.85, showing a slight decline of 0.77% over the past day. The stock is positioned neutrally from a technical perspective, with key support near $242 and resistance at $246. Fundamentally, the company exhibits strong profitability with a net income margin of 63.79% and has beaten earnings expectations in two of the last three quarters. Recent news highlights portfolio expansion, including a significant investment in the Bullabulling Gold Project and positive developments regarding the potential restart of the Cobre Panama mine.
The outlook for FNV is supported by analyst consensus, with a price target of $275 suggesting potential upside. Key opportunities include revenue growth from new projects and high profit margins. Risks involve execution on new investments, commodity price volatility, and geopolitical factors affecting mining operations. The balanced analyst rating split indicates cautious optimism for future performance.
Altria Group (MO) trades at $71.56, down 0.15% on the day, with a P/E of 15.07 and a net income margin of 39%. Recent earnings show mixed results, with a beat in Q1 2026 but a miss in Q4 2025 and Q2 2026. The technical outlook is bullish based on moving averages, but oscillators suggest caution. Strong cash flow supports a high dividend yield, though negative equity and regulatory risks persist.
The stock presents a high-yield opportunity with a solid dividend history, but faces headwinds from declining margins and a challenging regulatory environment. Analyst consensus is bullish with a $69.71 price target, yet investors must weigh the sustainability of dividends against underlying financial pressures and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Franco-Nevada Corporation
Franco-Nevada Corporation is a royalty and streaming company that finances mining and energy projects in exchange for royalty payments or the right to purchase output at set prices, holding a diversified portfolio across Precious Metals, Other Mining, and Energy (oil, gas, and natural gas liquids).
Read more on FNV →About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →
